BioMARC is a non-profit Biologics CDMO owned and operated by Colorado State University (CSU) serving biopharma companies and government agencies. BioMARC specializes in high containment to safely work in BSL- 2 and BSL-3, including handling CDC Tier 1 select agents. Development and manufacturing are performed under phase appropriate cGMP conditions for pre-clinical, clinical and commercial products. Services include process and method development, cell, bacteria, and virus banking, bulk drug manufacturing, stability programs, and aseptic fill-finish. Projects involve vaccines, therapeutics, diagnostic reagents, and novel cell based therapies in our FDA and CDC inspected state-of-the-art facility.